IRINOTECAN HYDROCHLORIDE AND CETUXIMAB WITH OR WITHOUT RAMUCIRUMAB IN TREATING PATIENTS WITH ADVANCED COLORECTAL CANCER WITH PROGRESSIVE DISEASE AFTER TREATMENT WITH BEVACIZUMAB-CONTAINING CHEMOTHERAPY: